Body Mass Index and Liver Stiffness Affect Accuracy of Ultrasonography in Detecting Steatosis in Patients With Chronic Hepatitis C Virus Genotype 1 Infection

被引:9
|
作者
Macaluso, Fabio Salvatore [1 ]
Maida, Marcello [1 ]
Camma, Calogero [1 ]
Cabibi, Daniela [2 ]
Alessi, Nicola [1 ]
Cabibbo, Giuseppe [1 ]
Di Marco, Vito [1 ]
Craxi, Antonio [1 ]
Petta, Salvatore [1 ]
机构
[1] Univ Palermo, Dipartimento Biochim Med Interna & Specialist, Sez Gastroenterol, Palermo, Italy
[2] Univ Palermo, Cattedra Anat Patol, Palermo, Italy
关键词
BLEP; Fibrosis; Evaluation; Cirrhosis; CHRONIC VIRAL-HEPATITIS; INSULIN-RESISTANCE; FIBROSIS; RELIABILITY; ULTRASOUND; DISEASE; BIOPSY; IMPACT;
D O I
10.1016/j.cgh.2013.09.059
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: Few studies have evaluated the accuracy of ultrasonography in detecting steatosis in patients with chronic hepatitis C. We assessed its accuracy in detecting steatosis and factors that affect its diagnostic performance in consecutive patients with chronic hepatitis C virus genotype 1 infection. METHODS: We analyzed data from 515 patients with chronic hepatitis C, confirmed by liver biopsy, assessing anthropometric, biochemical, metabolic, virologic, and ultrasonography features. Transient elastography was performed to measure liver stiffness. Steatosis was identified with ultrasonography based on detection of a bright liver echo pattern. RESULTS: Ultrasonography identified steatosis in 5% or more of parenchyma of the liver with 63.6% sensitivity, 90.4% specificity, an 87.5% positive predictive value (PPV), and a 70.3% negative predictive value (NPV). The higher the degree of steatosis (based on histology analysis), the higher the sensitivity values and NPVs (up to values of 75.3% and 93.8%, respectively, for steatosis in >= 30% of liver), and the lower the specificity values and PPVs (down to values of 69.8% and 31.7% for steatosis in >= 30% of liver, respectively). Body mass index of 30 kg/m(2) or greater (odds ratio, 2.761; 95% confidence interval, 1.156-6.595; P = .02) and liver stiffness measurements of 8.9 kPa or higher (odds ratio, 3.128; 95% confidence interval, 1.715-5.706; P < .001) were independent risk factors for false-negative results from ultrasonography when there was 5% or more steatosis, as well as when there was 10% or more, 20% or more, or 30% or more steatosis. CONCLUSIONS: Ultrasonography detects steatosis with low levels of accuracy in patients with chronic hepatitis C virus genotype 1 infection; it has low NPVs for amounts of steatosis of 5% or more and low PPVs for livers with moderate-severe amounts. Higher body mass indexes and liver stiffness measurements are associated with false-negative results in steatosis detection by ultrasonography.
引用
收藏
页码:878 / U209
页数:8
相关论文
共 50 条
  • [21] Evaluation of hepatic steatosis by ultrasound in patients with chronic hepatitis C virus infection
    Hirche, T. O.
    Ignee, A.
    Hirche, H.
    Schneider, A.
    Dietrich, C. F.
    LIVER INTERNATIONAL, 2007, 27 (06) : 748 - 757
  • [22] Clinicopathological features and genotype distribution in patients with hepatitis C virus chronic liver disease
    Abraham R.
    Ramakrishna B.
    Balekuduru A.
    Daniel H.D.J.
    Abraham P.
    Eapen C.E.
    Kurian G.
    Indian Journal of Gastroenterology, 2009, 28 (2) : 53 - 58
  • [23] Dynamics of liver stiffness by transient elastography in patients with chronic hepatitis C virus infection receiving direct-acting antiviral therapy-Results from the German Hepatitis C-Registry
    Knop, Viola
    Mauss, Stefan
    Goeser, Tobias
    Geier, Andreas
    Zimmermann, Tim
    Herzer, Kerstin
    Postel, Nils
    Friedrich-Rust, Mireen
    Hofmann, Wolf Peter
    JOURNAL OF VIRAL HEPATITIS, 2020, 27 (07) : 690 - 698
  • [24] Novel serum biomarkers modified by the body mass index z-score for the detection of liver fibrosis and steatosis in children with chronic hepatitis C
    Pokorska-Spiewak, Maria
    Kowalik-Mikolajewska, Barbara
    Aniszewska, Malgorzata
    Pluta, Magdalena
    Marczynska, Magdalena
    BMC INFECTIOUS DISEASES, 2017, 17
  • [25] Correlation between FIB4, liver stiffness and metabolic parameters in patients with HIV and hepatitis C virus co-infection
    Bruno, Raffaele
    Sacchi, Paolo
    Cima, Serena
    Maiocchi, Laura
    Patruno, Savino F. A.
    Klersy, Catherine
    Barbarini, Giorgio
    Zuccaro, Valentina
    Camma, Calogero
    Filice, Gaetano
    DIGESTIVE AND LIVER DISEASE, 2011, 43 (07) : 575 - 578
  • [26] Prevalence and predictors for compensated Advanced Chronic Liver Disease (c-ACLD) in patients with chronic Hepatitis Delta Virus (HDV) infection
    Couto, Ingrid
    Victoria, Marilu
    Veloso, Valdilea G.
    Rodrigues, Lorena
    Grinsztejn, Beatriz
    Lacerda, Marcus
    Victoria, Flamir
    Perazzo, Hugo
    PLOS ONE, 2017, 12 (03):
  • [27] Daclatasvir Plus Asunaprevir for the Treatment of Patients with Hepatitis C Virus Genotype 1b Infection: Real-World Efficacy, Changes in Liver Stiffness and Fibrosis Markers, and Safety
    Lee, Hye Won
    Oh, Se Rim
    Kim, Dong Yun
    Jeong, Yechan
    Kim, Seungtaek
    Kim, Beom Kyung
    Kim, Seung Up
    Kim, Do Young
    Ahn, Sang Hoon
    Han, Kwang-Hyub
    Park, Jun Yong
    GUT AND LIVER, 2018, 12 (03) : 324 - 330
  • [28] Update on the Treatment of Patients With Non-Genotype 1 Hepatitis C Virus Infection
    Mangia, Alessandra
    Mottola, Leonardo
    Piazzolla, Valeria
    CLINICAL INFECTIOUS DISEASES, 2013, 56 (09) : 1294 - 1300
  • [29] Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection
    Siddique, I
    Abu El-Naga, H
    Madda, JP
    Memon, A
    Hasan, F
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2003, 38 (04) : 427 - 432
  • [30] The Hepatic Expression of Vitamin D Receptor Is Inversely Associated With the Severity of Liver Damage in Genotype 1 Chronic Hepatitis C Patients
    Petta, Salvatore
    Grimaudo, Stefania
    Tripodo, Claudio
    Cabibi, Daniela
    Calvaruso, Marco
    Di Cristina, Antonietta
    Guarnotta, Carla
    Macaluso, Fabio Salvatore
    Minissale, Maria Giovanna
    Marchesini, Giulio
    Craxi, Antonio
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (01) : 193 - 200